Epigenetic modification may be useful in treating brain disorders
By Nuala Moran
Tuesday, February 18, 2014
CHICAGO – Evidence and understanding is mounting of the central role that epigenetic alterations of gene expression play in brain disorders ranging from schizophrenia to post-traumatic stress and Huntington’s disease, pointing the way to a swathe of potential new therapeutic targets.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.